ClassID:

94311

C07D219/12 - CPC Classification

Classification description:

Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system; Nitrogen atoms attached in position 9 Amino-alkylamino radicals attached in position 9

Recent Application in this class:
#1
20250360124
2025-11-27

NOVEL RAS INHIBITORS

#2
20250248992
2025-08-07

INNATE IMMUNE-ACTIVATING DRUG AND USE THEREOF

#3
20240391876
2024-11-28

QUINACRINE AND DERIVATIVES THEREOF FOR TREATMENT OF VIRAL INFECTIONS

#4
20210070712
2021-03-11

Dimeric Quinacrine Derivatives As Autophagy Inhibitors For Cancer Therapy

#5
20200407325
2020-12-31

NOVEL 1,4-BIS(3-AMINOPROPYL)PIPERAZINE DERIVATIVE AND ITS USE

#6
20200399214
2020-12-24

Compositions and methods for making donor-acceptor azetines

#7
20180290981
2018-10-11

1,4-bis(3-aminopropyl)piperazine derivative and its use

#8
20180290980
2018-10-11

Autophagy inhibitors

#9
20180111904
2018-04-26

Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy

#10
20180086753
2018-03-29

Fused-tricyclic inhibitors of KRAS and methods of use thereof

#11
20180086713
2018-03-29

CGAS in systemic lupus erythematosus (SLE)

#12
20180086712
2018-03-29

Asymmetric bis-acridines with antitumour activity and their uses

#13
20180072679
2018-03-15

1,4-bis(3-aminopropyl)piperazine derivative and its use

#14
20170022166
2017-01-26

HDMX inhibitors and their use for cancer treatment

#15
20160137607
2016-05-19

Autophagy Inhibitors

#16
20150005328
2015-01-01

Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

#17
20140148451
2014-05-29

Autophagy inhibitors

#18
20140066421
2014-03-06

Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

#19
20130197026
2013-08-01

Composition and methods for treating glioblastoma

#20
20130102627
2013-04-25

Acridines As Inhibitors Of Haspin And DYRK Kinases

#21
20130035351
2013-02-07

Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors

#22
20090149464
2009-06-11

Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases

#23
20090124001
2009-05-14

9-amino-acridine derivatives and their use for eliminating misfolded proteins

#24
20070099950
2007-05-03

Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain

#25
20060142323
2006-06-29

Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease

#26
20060030565
2006-02-09

Amide derivatives and nociceptin antagonists

#27
20050070573
2005-03-31

Aminoquinoline compounds